Eileen Brantley
Developmental Therapeutics Program
National Cancer Institute at Frederick
Building 1047
Room 7
USA
Name/email consistency: high
- Anti-tumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces single-strand breaks and DNA-protein cross-links in sensitive MCF-7 breast cancer cells. Brantley, E., Antony, S., Kohlhagen, G., Meng, L., Agama, K., Stinson, S.F., Sausville, E.A., Pommier, Y. Cancer Chemother. Pharmacol. (2006)